Skip to main content
. Author manuscript; available in PMC: 2019 Jan 3.
Published in final edited form as: Curr Otorhinolaryngol Rep. 2016 Apr 7;4(2):130–141. doi: 10.1007/s40136-016-0120-6

Table 1.

Results of studies of the epidemiology of olfactory disorders

Population n Age (range) Gender (% Female) Smell Test Major findings Strengths Weaknesses Reference
Skövde Sweden 1387 20–80 + 51.77 % self-report, SOIT -poorer-than normal odor detection sensitivity was 15.3% (self-report)
-the prevalence of olfactory dysfunction was 19.1%; 13.3% had hyposmia and 5.8% suffered from anosmia
population-based data across all ages; representative of the general adult Swedish population self-report 26; 27
Skövde Sweden 1713 13–80 + 52.13 % self-report =3.9% of the general population aged 13 years and older report having had parosmia (4.0% of the adults and 3.4% of the teenagers). added a teenage population; assessed qualitative disorders teenage data may be less reliable? 28
The Beaver Dam Study WI, USA 2491 53–97 58% SDOIT -prevalence of impaired olfaction was 24.5% extensive information available on potential risk factors limited generalizability to minority groups? 13
The Beaver Dam Offspring Study WI, USA 1993 21–84 54.4% SDOIT -prevalence of olfactory impairment was low at 3.8% in this primarily middle-aged cohort
-this increased with age (from 0.6% in those <35 years to 13.9% among those ≥65 years)
one of the few longitudinal studies extensive information available on potential risk factors may not be representative? 29
National Health Interview Survey (NHIS) USA 80,000 ≥18 * home interview -1.4% of US adults complained of an olfactory problem
-almost 40% of those who reported a chemosensory problem were ≥65 years
large sample likely underestimates actual prevalence due to self-report? 30
KNHANES South Korea (2009) 7306 20–95 56.7% questionnaire -prevalence of subjective olfactory disorders was 4.5% large sample provided a clinical association between olfactory dysfunction and mental health self-report, not strictly controlled 31
KNHANES South Korea (2010–201 1) 11972 ≥19 50.74 % questionnaire -prevalence of olfactory dysfunction was 5.0% large sample provided a clinical association between olfactory dysfunction and mental health unable to distinguish degrees of smell disturbance; cross-sectional 32
NSHAP, USA 3005 57–85 56.7% Odor ID test -prevalence of severe olfactory dysfunction was 2.7% nationally representative sample only a small percentage of the variance is explained 33
NSHAP, USA 1436 57–85 51.7% Odor ID test -odor identification is one of the strongest predictors of 5-year mortality well controlled no cause of death, no information on younger ages, acquired causes 1
OLFACAT Catalonia, Spain 9348 5–91 65.7% Odor ID test -prevalence of dysfunction was 19.4%
- a significant age-related decline in odor detection
large sample potential bias in this non-random sample; lack of ethnic diversity, socio-cultural class 36
Memory and Aging Project (MAP) IL, USA 481 mean age 80.6 ± 7.0 72.6% CC-SIT -prevalence of olfactory impairment was 55.3%
-impaired odor identification in old age is associated with impaired global cognition
high rate of participation in follow-up outstanding cognitive assessment select cohort of convenience; fewer women included 42
Memory and Aging Project (MAP) IL, USA 1162 mean age 79.7 ± 7.7 74.5% CC-SIT -difficulty identifying familiar odors in old age is associated with increased risk of death well characterized cohort select cohort; fewer women included 45
Blue Mountains Eye Study Australia 1636 ≥60 58.1% SDOIT -prevalence of olfactory impairment was 27.0%. high participation rate high follow-up rate cross-sectional, potential bias? 46
Bet.ula Sweden 1906 45–90 54.46 % SOIT -a gradual/linear deterioration in cued odor identification across the adult life span good demographic and cognitive variables, sample size cross-sectional 48
Honolulu-Asia Aging Study (HAAS) HI, USA 2267 71–95 0% CCSIT -olfactory deficits associated with the presence of incidental Lewybodies and PD longitudinal design, large sample size with excellent follow-up, well-validated test instruments men only; older age focused 39
*

not provided